Sertraline + Fluvoxamine vs Sertraline + Aripiprazole in Refractory OCD

Phase 4, randomised, open-label trial of fluvoxamine in obsessive compulsive disorder (OCD) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Yale-Brown Obsessive Compulsive Scale at 12 weeks and Ratio of Y-BOCS score reduction from baseline at 12 weeks. Status: unknown.